Eldopro Tablet (Erdostein)

Adult dose

Adults: Administer 300 mg of erdosteine orally 2~3 times daily. When administered for acute respiratory disease, do not use continuously for more than 10 days.

This medication should not be used in certain patients. Firstly, patients who are allergic to this medication or any of its components should not take it. Additionally, patients with liver cirrhosis or cystathionine synthase deficiency should not receive this medication, as its metabolite can interfere with the metabolism of methionine. Patients with peptic ulcers should also avoid this medication, as it can worsen symptoms. Patients with severe renal impairment, especially those with a creatinine clearance of less than 25 mL/min, and those with severe liver disease should not use this medication. Patients with mild or moderate liver impairment should use this medication cautiously and ensure that the daily dosage does not exceed 300 mg. In case of overdose, symptoms such as excessive sweating, dizziness, and facial flushing may occur. Neurological and respiratory adverse reactions, including headaches, cold symptoms, and breathing difficulties, have also been reported. Additionally, gastrointestinal adverse symptoms such as taste disturbance, nausea, vomiting, diarrhea, abdominal pain, heartburn, as well as skin reactions like urticaria, erythema, and eczema may occur. Various adverse reactions related to this medication have also been reported, including fatigue, dyspepsia, palpitations, facial or generalized edema, itching, weakness, confusion, and rash. Caution should be exercised when taken with expectorants, as it can lead to difficulty in expelling sputum from the bronchi, increasing the risk of bronchial infections and complications in bronchial contraction and relaxation. It is preferable for pregnant or potentially pregnant women and breastfeeding mothers not to take this medication. Although no special harm was found in animal experiments, safety for pregnant and lactating women has not been fully confirmed. This medication should be kept in a safe place out of the reach of children, and care should be taken not to transfer it to other containers, as this may pose a risk of accidents and quality deterioration.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• taste disturbance
• nausea
• vomiting
• diarrhea

Drug interactions

People taking cough medications should consult with their doctor or pharmacist while using this medication.

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. Additionally, it is advisable to store it at room temperature between 1 and 30 degrees Celsius.

Appearance

White oblong film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle